The European Patent Office (EPO) has published patent application EP4491152A1, detailing a method for manufacturing covered stents, the stents themselves, and their delivery systems. The patent, assigned to Jiangsu Polylive Medtech Co., Ltd., focuses on innovations within the prosthetics and medical device classifications.

This publication represents a new intellectual property filing and does not impose immediate regulatory obligations on manufacturers. However, companies operating in the covered stent market should be aware of this patent as it may affect future product development, market entry, or licensing strategies within the European Union.